Treatment of Helicobacter gastritis with IL-4 requires somatostatin
- PMID: 14555768
- PMCID: PMC240724
- DOI: 10.1073/pnas.2135193100
Treatment of Helicobacter gastritis with IL-4 requires somatostatin
Abstract
Fifty percent of the world's population is infected with Helicobacter pylori; however, treatment has been insufficient to eradicate the organisms due to rising antibiotic resistance. Helicobacter infection is characterized by induction of a T helper 1 lymphocyte (Th1) immune response, hypergastrinemia, and suppressed tissue somatostatin (SOM) levels. However, the mechanism by which the immune response regulates acid secretion is not known. We show here that treatment with IFN-gamma, a Th1 cytokine, was sufficient to induce gastritis, increase gastrin, and decrease SOM levels within 7 days. In contrast, the T helper 2 lymphocyte cytokine IL-4 increased SOM levels and effectively suppressed gastrin expression and secretion. This result demonstrated reciprocal regulation of acid regulatory peptides by immune modulators. IL-4 pretreatment prevented gastritis in infected wild-type but not in SOM null mice. Thus, the ability of IL-4 to oppose a Th1-mediated infection required SOM. Immunofluorescence was used to document the presence of IL-4 receptors on the gastric SOM-secreting cell (D cell). Moreover, IL-4 stimulated SOM release from primary D cell cultures. Treatment of mice chronically infected with Helicobacter felis for 2 mo with the SOM analogue octreotide resolved the inflammation. Thus, a mechanism by which IL-4 resolves inflammation in the stomach is by stimulating the release of SOM from gastric D cells.
Figures





Similar articles
-
Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice.J Immunol. 2000 Jul 15;165(2):1022-9. doi: 10.4049/jimmunol.165.2.1022. J Immunol. 2000. PMID: 10878379
-
Eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice.Helicobacter. 2005 Oct;10(5):407-15. doi: 10.1111/j.1523-5378.2005.00349.x. Helicobacter. 2005. PMID: 16181351
-
gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):32-40. doi: 10.1111/j.1440-1746.2005.04148.x. J Gastroenterol Hepatol. 2006. PMID: 16706809
-
The Helicobacter felis model of adoptive transfer gastritis.Immunol Res. 2005;33(2):183-94. doi: 10.1385/IR:33:2:183. Immunol Res. 2005. PMID: 16234583 Review.
-
The substance P and somatostatin interferon-gamma immunoregulatory circuit.Ann N Y Acad Sci. 1998 May 1;840:532-9. doi: 10.1111/j.1749-6632.1998.tb09592.x. Ann N Y Acad Sci. 1998. PMID: 9629280 Review.
Cited by
-
Helicobacter pylori: bacterial factors and the role of cytokines in the immune response.Curr Microbiol. 2010 Feb;60(2):143-55. doi: 10.1007/s00284-009-9518-4. Epub 2009 Oct 22. Curr Microbiol. 2010. PMID: 19847485
-
Essential role for macrophage migration inhibitory factor in gastritis induced by Helicobacter pylori.Am J Pathol. 2009 Apr;174(4):1319-28. doi: 10.2353/ajpath.2009.080708. Epub 2009 Mar 12. Am J Pathol. 2009. PMID: 19286569 Free PMC article.
-
Helicobacter pylori induction of the gastrin promoter through GC-rich DNA elements.Helicobacter. 2010 Oct;15(5):438-48. doi: 10.1111/j.1523-5378.2010.00787.x. Helicobacter. 2010. PMID: 21083750 Free PMC article.
-
Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.Clin Microbiol Rev. 2006 Oct;19(4):597-613. doi: 10.1128/CMR.00006-06. Clin Microbiol Rev. 2006. PMID: 17041136 Free PMC article. Review.
-
STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.J Clin Invest. 2008 May;118(5):1727-38. doi: 10.1172/JCI34944. J Clin Invest. 2008. PMID: 18431520 Free PMC article.
References
-
- McColl, K. E., el-Omar, E., Gillen, D. & Banerjee, S. (1997) Semin. Gastrointest. Dis. 8 142-155. - PubMed
-
- el-Omar, E. M., Penman, I. D., Ardill, J. E., Chittajallu, R. S., Howie, C. & McColl, K. E. (1995) Gastroenterology 109 681-691. - PubMed
-
- Martinez, V., Curi, A. P., Torkian, B., Schaeffer, J. M., Wilkinson, H. A., Walsh, J. H. & Tache, Y. (1998) Gastroenterology 114 1125-1132. - PubMed
-
- Correa, P. (1992) Cancer Res. 52 6735-6740. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases